Market revenue in 2023 | USD 27.3 million |
Market revenue in 2030 | USD 33.2 million |
Growth rate | 2.8% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.41% in 2023. Horizon Databook has segmented the South Africa point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
8.6.2.4 COMPETITIVE/MARKET SCENARIO High prevalence of malaria and other infectious diseases along with the large population in South Africa are the major factors propelling market growth in this region. The country also faced a severe impact from the COVID-19 pandemic with over 3 million confirmed cases of COVID-19 and over 100,000 deaths reported due to the disease, in the period between 3rd January 2020 and 29th April 2022.
To boost COVID-19 testing, the South African government implemented an aggressive testing strategy, which involves large-scale community testing through door-to-door screening campaigns. The high incidence of this infection in South Africa is responsible for boosting the demand for paid near-patient testing as people avoid seeking tests in public hospitals and laboratories to prevent further virus spread.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account